Research on CBD for Autoimmune Disorders


(2017) Cannabidiol as a Therapy for ASIA Syndrome? An Editorial on a Novel Study.


(2017) Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.


(2016) Cannabidiol: a potential treatment for post Ebola syndrome?


(2016) Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.


(2016) Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.


(2015) Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.


(2015) The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.


(2015) A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.


(2015) HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells.


(2015) Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells.


(2015) Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.


(2014) Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.


(2013) Cannabinoids decrease the th17 inflammatory autoimmune phenotype.


(2013) Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.


(2013) Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.


(2012) Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.


(2011) Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.


(2011) Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.


(2010) Acute and chronic cannabinoid extracts administration affects motor function in a CREAE model of multiple sclerosis.


(2009) Cannabidiol-induced lymphopenia does not involve NKT and NK cells.


(2008) Cannabidiol arrests onset of autoimmune diabetes in NOD mice.


(2006) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.


(1998) Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells.